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Abstract 
Allergy diseases tend to increase with variety of clinical manifestations. To date, pharmacotherapy 
do not treat the underlying disease. Many researches concerned to study new approach of allergy therapy 
which need allergy mouse model for evaluation. This study was aimed to compare the effectiveness of two 
treatment methods by using ovalbumin for allergy sensitization. This study was conducted in PT.Bimana 
Indomedical animal facility Bogor on June until September 2016. Six mice were divided into 2 groups. First 
group was sensitized by ovalbumin 100ug subcutaneous (sc) day-0, 50 ug intra peritoneal (ip) day-14 and 
100 ug intranasal (in) day-21. Second group was sensitized by ovalbumin 10 ug ip day-0 and day-7, 10 ug in 
day-21, 22, and 23. Body weight, hematology parameters (red blood cells, white blood cells, hemoglobin and 
hematocrit) and total IgE concentration of day-0 (pre-treatment) and day 24 (post-treatment) were measured. 
The results showed that there was an increase of mice body weight of both treatment group, while hematology 
changes of pre and post treatment were not significantly different (paired t-test). Whereas the increase in total 
IgE pre and post treatment was significantly different between the two groups (paired t-test). In conclusion, the 
second allergy sensitization method is better than the first allergy sensitization method.
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Perbandingan Mencit yang Disensitisasi dengan Ovalbumin untuk Model 
Alergi: Suatu Studi Pendahuluan
Abstrak 
Penyakit alergi cenderung meningkat dengan berbagai manifestasi klinis. Sampai saat ini farmakoterapi 
tidak mengatasi penyakit yang mendasarinya, sehingga banyak penelitian yang difokuskan untuk mempelajari 
pendekatan baru terapi alergi yang memerlukan model hewan coba alergi untuk evaluasi. Penelitian ini bertujuan 
untuk membandingkan efektifitas dua metode perlakuan dengan menggunakan ovalbumin untuk sensitisasi 
alergi. Penelitian ini dilakukan di fasilitas hewan coba PT. Bimana Indomedical Bogor pada bulan Juni sampai 
September 2016. Enam mencit dibagi menjadi 2 kelompok. Kelompok pertama disensitisasi dengan ovalbumin 
100ug subkutan (sc) hari ke-0, 50 ug intra peritoneal (ip) hari ke-14 dan 100 ug intranasal (in) hari ke-21. 
Kelompok kedua disensitisasi dengan ovalbumin 10 ug ip hari ke-0 dan hari ke-7, 10 ug intra nasal pada hari 
ke-21, 22, dan 23. Berat badan, hematologi (eritrosit, lekosit, hemoglobin dan hematokrit) dan konsentrasi IgE 
total hari ke-0 (sebelum perlakuan) dan hari ke-24 (setelah perlakuan) diukur. Hasil penelitian menunjukkan 
terdapat peningkatan berat badan mencit dari kedua kelompok setelah perlakuan, namun tidak disertai dengan 
perubahan hematologi yang berbeda bermakna (uji t berpasangan). Sedangkan peningkatan IgE total sebelum 
dan setelah perlakuan kelompok kedua berbeda bermakna (uji t berpasangan) dibandingkan kelompok pertama. 
Penggunaan ovalbumin total per mencit kelompok pertama lebih tinggi dari kelompok kedua. Metode sensitisasi 
alergi kelompok perlakuan kedua lebih baik dari sensitisasi alergi kelompok perlakuan pertama 
Kata kunci: alergi; mencit; ovalbumin; total IgE. 
184
Febriana Catur Iswanti, et al eJKI Vol. 6, No. 3, Desember 2018
Introduction 
Allergy is a hypersensitivity reaction caused by 
a certain immune mechanism. In various regions in 
Indonesia, the incidence of allergies varies from 3% 
to 60%. Although influenced by subjects morbidity 
characteristics and design of the study, the figures 
above clearly indicate that more and more allergic 
cases are reported.1 Allergic manifestation are 
asthma, rhinitis, conjunctivitis, anaphylaxis, drug-, 
food, insects’ allergy etc. According to World Health 
Organization data, hundreds millions of people have 
rhinitis all over the world and  it is estimated that 235 
million people have asthma.2 Pharmacotherapy by 
using antihistamine, corticosteroids and several 
symptomatic drugs have been shown to be 
effective in reducing symptoms however do not 
treat underlying allergy and disease progression.2, 3 
Immunotherapy was reported as a highly potential 
treatment for allergy. Sub cutaneous and sublingual 
immunotherapy were approved by World Allergy 
Organization and still under development studies. Many 
researches have been conducted to establish new 
approach of allergy therapy. These studies explored 
about Toll like receptor agonists, cytokine blocker and 
transcription factor inhibitor.3 Allergy mouse model 
became important for in vivo study model. Therefore, 
this study focuses to establish allergy mouse model by 
using ovalbumin sensitization.
Methods 
This study was an in vivo experimental study 
on Balb/c mice, and approved by  Animal Care 
and Use Committee (ACUC) no. R.04-16-IR. 
Balb/c mice was obtained from PT. Indo Ani Lab. 
Animal was adapted and given food ad libitum for 
2 weeks in room temperature.  Animal experiment 
was conducted in PT. Bimana Indomedical animal 
study facility Bogor on June until September 2016. 
Hematology measurement was conducted in 
pathology laboratory, Primate Research Center-
Bogor Agriculture University, Indonesia. While total 
IgE concentration was measured by sandwich 
ELISA method in Biochemistry laboratory, Faculty 
of Medicine Universitas Indonesia (FMUI).   
Six Balb/c mice were divided into 2 groups, 
induced by ovalbumin to prepare allergic mice. 
First group was injected by subcutaneous 100ug 
ovalbumin in 2% alhydrogel on day-0 followed 
by intraperitoneal injection of 50 ug ovalbumin in 
2% alhydrogel on day-14 (as shown in figure 1A). 
One hundred micrograms ovalbumin was given to 
Balb/c mice by drops intranasal on day-21.4 Second 
group of mice was injected by intraperitoneal 10 ug 
ovalbumin in 2% alhydrogel on day-0 and day 7 
respectively. Ten micrograms ovalbumin was given 
to Balb/c mice by drops intranasal on day-21, 22 
and 23 respectively (as shown in Figure 1B).5
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Figure 1. Sensitization Procedure of Allergy Mice. A. First Group Treatment;             
B. Second Group Treatment 
 
On day-0 before treatment, mice body weight was measured by using digital 
scale (ACIS). Mice were anaesthetized by using 0.03 ml ketamine (120 mg/kg) and 0.01 
ml xylazine (5 mg/kg) intraperitoneally.  After anesthesia procedure, ±100uL blood was 
collected from orbital vein for hematology and total IgE measurements.  
On day-24 allergy induction procedure according to the protocol, mice body 
weight was measured by using digital scale (ACIS). Mice were anaesthetized by using 
intraperitoneal 0.03 ml ketamine (120 mg/kg) and 0.01 ml xylazine (5 mg/kg) then 
intracardial blood samples were obtained by syringe injection directly to mice cardiac 
under anesthesia.   
After blood collection, cervical dislocation was done for euthanasia of mice. 
Blood was divided into 2 parts, ±100 µL for hematology examination and the rest was 
processed by 1000x g centrifugation for 10 minutes, then blood plasma was stored at -
20°C. Hematology examination was performed in pathology laboratory of Primate 
Research Center-Bogor Agriculture University. While total IgE level measurement was 
performed in Department of Biochemistry FMUI laboratory by sandwich ELISA kit 
(eBioscience) following manual instruction.  
Allergy sensitization results are as follows, from 6 mice sensitized with 
ovalbumin following procedure, there were no pain symptoms that required particular 
treatment or death of all treatment group until day-24. Procedure for allergic induction is 
presented in the Figure 2.  
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Figure 1. Sensitization Procedure of Allergy Mice.
A. First Group Treatment;            
B. Second Group Treatment
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On day-0 before treatment, mice body weight 
was measured by using digital scale (ACIS). Mice 
were anaesthetized by using 0.03 ml ketamine 
(120 mg/kg) and 0.01 ml xylazine (5 mg/kg) 
intraperitoneally.  After anesthesia procedure, 
±100uL blood was collected from orbital vein for 
hematology and total IgE measurements. 
On day-24 allergy induction procedure according 
to the protocol, mice body weight was measured by 
using digital scale (ACIS). Mice were anaesthetized 
by using intraperitoneal 0.03 ml ketamine (120 mg/
kg) and 0.01 ml xylazine (5 mg/kg) then intracardial 
blood samples were obtained by syringe injection 
directly to mice cardiac under anesthesia.  
After blood collection, cervical dislocation was 
done for euthanasia of mice. Blood was divided into 
2 parts, ±100 µL for hematology examination and 
the rest was processed by 1000x g centrifugation 
for 10 minutes, then blood plasma was stored at 
-20°C. Hematology examination was performed in 
pathology laboratory of Primate Research Center-
Bogor Agriculture University. While total IgE level 
measurement was performed in Department of 
Biochemistry FMUI laboratory by sandwich ELISA 
kit (eBioscience) following manual instruction. 
Allergy sensitization results are as follows, 
from 6 mice sensitized with ovalbumin following 
procedure, there were no pain symptoms that 
required particular treatment or death of all 
treatment group until day-24. Procedure for allergic 
induction is presented in the Figure 2. 
Results
Comparison of mice body weight in the first 
treatment group were significantly different between 
pre and post treatment (p <0.05) by using paired t 
test. Whereas in the second treatment group there 
were no differences in body weight before and 
after treatment (p <0.05, paired t test). Comparison 
of body weight between the first and the second 
treatment groups is presented in Figure 3. 
4 
 
 
 
Figure 2. Allergy Sensitization Procedure of Mice, A. Weighing of Balb / C mice; B. Intraperitoneal 
Injection of Ovalbumin; C. Subcutaneous Ovalbumin Injection,;D. Intracardial End Point 
Blood Collection 
 
Results 
Comparison of mice body weight in the first treatment group were significantly 
different between pre and post treatment (p <0.05) by using paired t test. Whereas in the 
second treat ent group t ere were no differe ces in body weight before and after 
treatment (p <0.05, paired t test). Comparison of body weight between the first and the 
second treatment groups is presented in Figure 3.  
 
 
 
Figure 3. Comparison of Ovalbumin Induced Allergy Mice Body Weight  
 
Figure 4 shows the comparison of hematology in ovalbumin induced allergy 
mice. Both of treatment group did not show statistical difference of white blood cells, red 
blood cells, hemoglobin and hematocrit between pre and post treatment (p>0.05, paired 
t test). 
 
Treatment group 1 Treatment group 2
Pre 22.1 24.5
Post 23.4 25.5
0
5
10
15
20
25
30
Bo
dy
 w
ei
gh
t (
g)
Pre
Post
*
*
*
A
A
A 
D
A
A 
C
A
A 
B
A
A 
Figure 2. Allergy Sensitization Procedure of Mice, A. Weighing of Balb / C mice; B. Intraperi-
toneal Injection of Ovalbumin; C. Subcutaneous Ovalbumin Injection,;D. Intracardial 
End Point Blood Collection
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in ovalbumin induced allergy mice. Both of 
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Figure 4. Comparison of Ovalbumin Induced Allergy Mice Hematology. A. Treatment Group 1; B. 
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Comparison of total IgE concentration is presented in Figure 5. Post treatment 
total IgE concentration (2495.69±2761.38 ng/mL) of treatment group 1 was higher than 
the pretreatment total IgE concentration (847.70±515.52 ng/mL) although it was not 
statistically significant. Meanwhile, post treatment total IgE concentration of treatment 
group 2 (10606.32±4343.65 ng/ mL) was significantly higher than the pretreatment total 
IgE concentration (5676.72.70±4804.57 ng/mL) by using paired t-test (p<0.05). 
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Figure 4. Comparison of Ovalbumin Induced Allergy Mice Hematology. A. Treatment Group 1; B. Treatment 
Group 2. WBC: White Blood Cells (x103 cells/uL). RBC: Red Blood Cells (x106 cells/uL) 
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Comparison of total IgE concentration is 
presented in Figure 5. Post treatment total IgE 
concentration (2495.69±2761.38 ng/mL) of 
treatment group 1 was higher than the pretreatment 
total IgE concentration (847.70±515.52 ng/
mL) although it was not statistically significant. 
Meanwhile, post treatment total IgE concentration 
of treatment group 2 (10606.32±4343.65 ng/ mL) 
was significantly higher than the pretreatment total 
IgE concentration (5676.72.70±4804.57 ng/mL) by 
using paired t-test (p<0.05).
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Figure 5. Comparison of Ovalbumin Induced Allergy Mice Total IgE Concentration  
 
 
Discussions  
Animal model of acute allergic response has been widely studied.6 Extended 
studies of allergy including pathogenesis, diagnosis, and drug development have been 
conducted. Drug development study needs animal model to investigate the effects of 
drug candidate. It is important to establish allergy mouse model which could mimic 
allergy response in human before drug application in clinical trial. In vivo animal models 
are the most appropriate tool for studying drug due to intact immune system and 
respiratory system.7 
Mice is a popular animal model of the most common clinical manifestation of 
allergy namely asthma. Mice have several advantages compared with other species 
including better understanding on genetic, easy to manipulate outcomes by using 
transgenic technology, relatively cheap and easily sensitized by using a number of 
antigens.7 
In this study, we used Balb/c mice as allergy animal model. The most commonly 
used strain of mouse for antigen challenge is Balb/c due to ability to develop Th2 biased 
immune response.7 However, the other strain (C57BL/6 and A/J) reported to be 
alternative strain for allergy as well. Balb/c mice produce higher level of specific antibody 
anti-ovalbumin than C57BL/6 and A/J. Furthermore, Th2 cytokines production including 
IL-4 and IL-5 concentration higher than these strain.8 
Ovalbumin was used in this study as allergen for mice sensitization. Ovalbumin 
is derived from chicken egg, frequently used for allergic pulmonary inflammation in 
laboratory rodent. However, ovalbumin is not a common allergen of human asthma. The 
other alternative  allergen which have clinical relation in human is house dust mite and 
coackroch.9 Use of ovalbumin free adjuvant intra peritoneally was reported to induce 
allergy immune response on Balb/c mice.10 
It is well known that allergy is a chronic disease. To mimic allergy pathogenesis, 
mouse model should be treated with sensitization phase which induce acute immune 
response and followed by challenge to induce late phase immune response mediated by 
cytokines and chemokines.11 
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could mimic allergy response in human before drug 
application in clinical trial. In vivo animal models 
are the most appropriate tool for studying drug due 
to intact immune system and respiratory system.7
Mice is a popular animal model of the most 
common clinical manifestation of allergy namely 
asthma. Mice have several advantages compared 
with other species includi g better understanding 
on genetic, easy to manipulate outcome  by using 
transgenic technology, relatively cheap and easily 
sensitized by usi g a number of antigens.7
In this study, we used Balb/c mice as allergy 
animal model. The most commonly used strain of 
mouse for antigen challenge is Balb/c due to ability 
to develop Th2 biased immune response.7 However, 
the other strain (C57BL/6 and A/J) reported to be 
alternative strain for allergy as well. Balb/c mice 
Figure 5. Comparison of Ovalbumin Induced Allergy Mice Total IgE Concentration 
produce higher level of specific a tibody anti-
ovalbumi  than C57BL/6 and A/J. Furthermore, 
Th2 cytokin s production including IL-4 and IL-5 
concentration higher than these strain.8
Ovalbumin was used in this study as allergen 
for mice sensitization. Ovalbumin is derived from 
chicken egg, frequently used for allergic pulmonary 
inflammation in laboratory rodent. However, 
ovalbumin is not a common allergen of human 
asthma. The other alternative  allergen which have 
clinical relation in human is house dust mite and 
coackroch.9 Use of ovalbumin free adjuvant intra 
peritoneally was reported to induce allergy immune 
response on Balb/c mice.10
It is w ll known that allergy is a chronic disease. 
To mimic allergy pathogenesis, m us model 
shoul  be treat d with sensitizatio  phase which 
induce acute immune response and followed by 
challenge to induce late phase immune response 
mediated by cytokines and chemokines.11
In this study we compared 2 methods which both 
use ovalbumin as allergen for short term ovalbumin 
challenge. Differences of these methods are route 
of administration, dosage of ovalbumin and method 
of challenge. In the first treatment group, ovalbumin 
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was injected subcutaneous on day-0 followed by 
intraperitoneal injection on day-14 and challenge 
by single dose of intranasal ovalbumin. While in the 
second treatment group, ovalbumin was injected 
intraperitoneally on day-0 and day-7. This treatment 
followed by 3 dosage intranasal ovalbumin challenge 
on day-21, 22 and 23. 
Subcutaneous, intraperitoneal and intravenous 
administrations are the most common route of 
substance injection in mice. The rate of absorption 
depends on route of administration. The most 
rapid absorption of substance will be achieved 
by intravenous injection. While intraperitoneal 
injection absorption rate is one-quarter to one-
half of intravenous route due to the large surface 
area of abdominal cavity. Subcutaneous injection 
absorption rate is lower than intravenous and 
intraperitoneal administration.12 In contrary, recent 
study reported that subcutaneous injection was 
superior than the intraperitoneal route. Both 
methods increased house dust mite (Der p) specific 
IgE however only subcutaneous route shows 
significant airway remodelling.13
Alhydrogel was used as adjuvant in this 
study due to availability and ease in preparation. 
Adjuvant is a substance that enhances T and B cell 
activation of antigen-presenting cells. Alhydrogel 
contain alum which is regularly used as adjuvant in 
mouse model. However, a study reported that sub 
cutaneous OVA adjuvant free protocol generates a 
phenotype similar to OVA intra peritoneal protocol 
as well.14
Dosage of ovalbumin which was used in the 
first treatment group was higher than the second 
treatment group. From both methods, there were 
no incidence of death. Post treatment body weight 
of the first group was significantly higher than the 
pretreatment. The same result was seen on second 
group as well although not statistically significant. 
These results showed that ovalbumin sensitization 
did not cause severe systemic response on mice. 
This is characterized by no decrease of mice 
appetite and body weight.
Hematology examination results of both 
methods including red blood cells count, white 
blood cells count, hemoglobin count and 
hematocrit percentage show no difference between 
pretreatment and post treatment. Reference value 
for mice white blood cells count is 6000-15000 
cells/uL, hemoglobin 10.2-16.6 g/dL and hematocrit 
39-49%.15 This results show no important effect of 
ovalbumin on hematology parameters. Although 
decrease of white blood cells and hematocrit value 
on second treatment group, it was not statistically 
different between pre and post treatment.
Post treatment total IgE of both methods 
showed higher concentration than pretreatment. 
Meanwhile, second treatment group showed 
significantly statistical difference by pair t-test. Total 
IgE increase show effective induction of allergy. 
In allergy individual, IgE is highly produced as 
response against allergen. IgE synthesis regulation 
depend on individual tendency to increase Th2 
response against allergen since Th2 type cytokines 
induce isotype switching of heavy chain to IgE class 
on B cells.16 Total IgE level usually used for atopy 
marker in human although approximately half of 
allergic patients show normal range IgE.3 Therefore, 
increase of total IgE could be an important 
parameter of allergy. Ideally, this result should be 
followed up by specific IgE measurement. In this 
research, considering the limitation of diagnostic kit 
for this purpose, total IgE level was used as allergy 
parameter in mice.
IgE antibody production is induced by Th2 and 
Tfh after allergen stimulation. Two of cytokines 
secreted by Th2 and Tfh are IL-4 and IL-13. 
IgE bind FcεRI on mast cells and basophil.16,17 
Subsequent allergen stimulation caused mast 
cells and basophil activation. Activated mast cells 
and basophil induce three biological responses 
namely granule release, synthesis and secretion 
of lipid mediators and synthesis and secretion of 
cytokines. This causes various clinical symptoms 
of allergies.17 IgE antibodies are responsible for 
mast cell sensitization and antigen recognition for 
immediate type hypersensitivity reactions. IgE is 
an antibody isotype contain ε heavy chain. IgE is 
the most efficient in Fc receptors binding on mast 
cells and activating these cells compared to other 
isotypes.16,17 
In this study, allergy sensitization of both group 
successfully increased total IgE concentration. 
Allergy stimulation of second group seems superior 
than first group as shown by enhancement of total 
IgE production. The other parameters showed 
no significant difference between post treatment 
compared to pretreatment. Whereas total 
ovalbumin concentration volume needed for the 
allergy sensitization of second treatment group (50 
ug/mouse) was lower than first treatment group 
(250 ug/mouse).
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Conclusion 
In this preliminary study, allergy sensitization of 
both treatment groups successfully increase total 
IgE concentration which is one of the important 
parameters of allergy condition. Considering rise of 
total IgE concentration and total albumin volume, 
second treatment method by using intraperitoneal 
sensitization and intranasal challenge is superior 
than first treatment method which uses combination 
of subcutaneous and intraperitoneal sensitization 
followed by intranasal challenge. 
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